Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface (EML-MSO)

Clinical Trial ID NCT04198740

Rank	Title	Journal	Year	PubWeight™‹?›
1	Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors.	Genome Biol	2006	1.84
2	Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.	Mol Vis	2010	1.54
3	Investigation of the human tear film proteome using multiple proteomic approaches.	Mol Vis	2008	1.45
4	In-depth analysis of the human tear proteome.	J Proteomics	2012	1.24
5	A dataset of human cornea proteins identified by Peptide mass fingerprinting and tandem mass spectrometry.	Mol Cell Proteomics	2005	0.97
6	Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome.	PLoS One	2012	0.94
7	Lacritin and the tear proteome as natural replacement therapy for dry eye.	Exp Eye Res	2013	0.87
8	Review of application of mass spectrometry for analyses of anterior eye proteome.	World J Biol Chem	2014	0.79
9	Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.	EPMA J	2016	0.78
10	The TFOS international dry eye workshop II: Report of the Tear Film Subcommittee.	Ocul Surf	2017	0.75